| Dr Golnaz Saedi, MD | |
|
7320 Woodlake Ave, Suite 170, West Hills, CA 91307-1468 | |
| (818) 888-7090 | |
| Not Available |
| Full Name | Dr Golnaz Saedi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 17 Years |
| Location | 7320 Woodlake Ave, West Hills, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134340862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A96736 (California) | Primary |
| Entity Name | Golnaz Saedi, M.d., Inc. A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801041934 PECOS PAC ID: 0648332361 Enrollment ID: O20081215000213 |
News Archive
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at Huntsman Cancer Institute at the University of Utah to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism.
We are in need of a social security fund on a global scale. That is what scientists of the Institute of Tropical Medicine Antwerp argue in a Viewpoint in the leading medical journal The Lancet. Such a 'Global Fund for Health' would make the use of international donor money a lot more transparent and efficient.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer.
Whitehead Institute scientists have created a method that site-specifically modifies proteins to exert control over their properties when administered therapeutically. The technique should be useful to increase potency, slow metabolism, and improve thermal stability of therapeutically useful proteins, such as interferon alpha 2 (IFN-alpha 2), which is used to treat variety of diseases, including leukemia, melanoma, and chronic hepatitis C.
Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man's risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Golnaz Saedi, MD 7320 Woodlake Ave, Suite 170, West Hills, CA 91307-1468 Ph: (818) 888-7090 | Dr Golnaz Saedi, MD 7320 Woodlake Ave, Suite 170, West Hills, CA 91307-1468 Ph: (818) 888-7090 |
News Archive
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at Huntsman Cancer Institute at the University of Utah to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism.
We are in need of a social security fund on a global scale. That is what scientists of the Institute of Tropical Medicine Antwerp argue in a Viewpoint in the leading medical journal The Lancet. Such a 'Global Fund for Health' would make the use of international donor money a lot more transparent and efficient.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer.
Whitehead Institute scientists have created a method that site-specifically modifies proteins to exert control over their properties when administered therapeutically. The technique should be useful to increase potency, slow metabolism, and improve thermal stability of therapeutically useful proteins, such as interferon alpha 2 (IFN-alpha 2), which is used to treat variety of diseases, including leukemia, melanoma, and chronic hepatitis C.
Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man's risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.
› Verified 9 days ago
Roger Amerian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 7320 Woodlake Ave, Ste 290, West Hills, CA 91307 Phone: 818-716-6446 Fax: 818-716-9869 | |
Dr. Christopher Nemer Hage, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7345 Medical Center Dr, Suite 220, West Hills, CA 91307 Phone: 818-702-9962 Fax: 818-702-0016 | |
Benjamin J Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23101 Sherman Pl, Suite 110, West Hills, CA 91307 Phone: 818-702-8800 Fax: 818-702-0080 | |
Dr. Jonathan Scott Matthew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7301 Medical Center Dr, Suite 201, West Hills, CA 91307 Phone: 818-346-9911 Fax: 818-346-2857 | |
Barbara Callahan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7301 Medical Center Dr #402, West Hills, CA 91307 Phone: 818-227-0070 | |
Jon F Willen, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7230 Medical Center Dr, #203, West Hills, CA 91307 Phone: 818-226-6811 Fax: 818-226-6810 |